Roche Holding Ltd · SIX:RO

Roche — Technical Presentation (February 2025)

27 slides from Roche's technical presentation, Feb 20, 2025

  1. Slide 1: Sequencing by Expansion (SBX)/AGBT 2025 Virtual IR Event

    Sequencing by Expansion (SBX)/AGBT 2025 Virtual IR Event Feb 20th 2025

  2. Slide 2: Welcome

    Welcome Bruno Eschli Head of Investor Relations

  3. Slide 3: Agenda

    Agenda Welcome Bruno Eschli, Head of Investor Relations Sequencing by Expansion (SBX) Matt Sause, CEO Roche Diagnostics Josh Lauer, Global Head of Customer Area Molecular Labs Q&A Birgit Masjost, Investor Relations Officer Matt Sause, CEO Roche Diagnostics Josh Lauer, Global Head of Customer Area Mo

  4. Slide 4: IR events currently planned for 2025

    IR events currently planned for 2025 Additional events driven by readouts Immunology/WCN Update on NGS Neurology Update Diagnostics Day Pharma Day 7 Feb 20 Feb 4 Apr 27 May 22 Sep 16:30 – 17:30 CET 20:30 - 21:30 CET 16:00 – 17:30 CEST 14:00 - 16:30 CEST tbd Virtual event Virtual event Virtual event

  5. Slide 5: Sequencing by Expansion (SBX)

    Sequencing by Expansion (SBX) Matt Sause CEO Roche Diagnostics Josh Lauer Global Head of Customer Area Molecular Labs

  6. Slide 6: Introducing Roche SBX technology

    Introducing Roche SBX technology The NGS market was valued at USD 6.4b (2024) and projected to grow at 9% per year from 2024 to 2027 driven by clinical and biopharma segments1 Growth in clinical segment is driven by applications such as therapy selection and monitoring in oncology where Roche has a

  7. Slide 7: Roche sequencing portfolio today

    Roche sequencing portfolio today From leading tools and technologies to solutions in oncology Biological Obtaining meaningful & Actionable Sample preparation Sequencing sample actionable insights report KAPA KAPA library target prep1 enrichment1 navify® Mutation Profiler AVENIO Edge System2 3rd part

  8. Slide 8: Building towards a differentiated sequencing ecosystem

    Building towards a differentiated sequencing ecosystem Iterative development through NGS value chain for tools and solutions Biological Obtaining meaningful & Actionable Sample preparation Sequencing sample actionable insights report KAPA KAPA Consumables & Informatics library target reagents3 solut

  9. Slide 9: Introducing SBX technology

    Introducing SBX technology Combination of two powerful innovations creates a leap forward in sequencing SBX chemistry High-throughput sensor module Unique speed and flexibility + = • Novel chemistry from Stratos* turns DNA • 8 million microwell array CMOS chip from • Clear, discrete signal combines

  10. Slide 10: Benefits of SBX technology

    Benefits of SBX technology Designed to deliver flexibility and throughput with potential for future improvement Flexible operation Read length Batch flexibility Simplex: 50 - 1000+ bp Duplex: 150 - 350 bp (insert) Accuracy Urgent samples Q39 average for HG001 (Duplex) Sample to VCF in < 7 hours F1 9

  11. Slide 11: Roche's high-throughput sequencing solution (in development)

    Roche’s high-throughput sequencing solution (in development) Separate Xpandomer synthesis from single molecule measurement for maximum flexibility Library Preparation Synthesis Instrument Sequencing Instrument Multiplexed & indexed libraries Synthesis of Xpandomer Single molecule sequencing on molec

  12. Slide 12: Roche's high-throughput sequencing solution (in development)

    Roche’s high-throughput sequencing solution (in development) Library Preparation Synthesis Instrument Sequencing Instrument Multiplexed & indexed libraries Synthesis of Xpandomer Single molecule sequencing on molecules a CMOS-based Sensor module Illustrations not to scale; CMOS=complementary metal-o

  13. Slide 13: Xpandomer synthesis

    Xpandomer synthesis Automated instrument has flexibility to synthesize up to 4 separate library pools in < 4 hours Flexible operation Resulting Xpandomer molecule • Automated instrument creates Xpandomers from • Highly engineered polymerase translates original DNA sequence into an entirely new multi

  14. Slide 14: Roche's high-throughput sequencing solution (in development)

    Roche’s high-throughput sequencing solution (in development) Library Preparation Synthesis Instrument Sequencing Instrument Multiplexed & indexed libraries Synthesis of Xpandomer Single molecule sequencing on molecules a CMOS-based Sensor module Illustrations not to scale; CMOS=complementary metal-o

  15. Slide 15: Xpandomer sequencing

    Xpandomer sequencing High-throughput sequencing carried out on a reusable sensor module Sensor module Pore formation & reuse Controllable signal Setup Initialize run Sequencing System clean Amplitude Signal Translated Xp basecalls • 8 million microwell CMOS array • Xpandomers are threaded through po

  16. Slide 16: Roche's high-throughput sequencing solution (in development)

    Roche’s high-throughput sequencing solution (in development) Library Preparation Synthesis Instrument Sequencing Instrument Multiplexed & indexed libraries Synthesis of Xpandomer Single molecule sequencing on molecules a CMOS-based Sensor module Illustrations not to scale; CMOS=complementary metal-o

  17. Slide 17: SBX library structures and workflows

    SBX library structures and workflows Different approaches for different applications SBX-Duplex SBX-Duplex SBX-Simplex SBX Simplex Library Xpandomer High Accuracy Ultra-High Throughput 200-300 bp < 200 bp 200 - 500 bp 500 -1500 bp Potential WGS/WES WTS WTS DNA Structural Variants Future Somatic Onco

  18. Slide 18: SBX-Duplex variant calling performance

    SBX-Duplex variant calling performance Potential for clinical accuracy using Roche’s modified GATK and Google’s DeepVariant GATK + Roche Machine Learning DeepVariant F1 Score F1 Score Mean Insert Sample SNV Indels SNV Indels Read Length HG001 235 99.77% 99.54% 99.80% 99.56% • 1 hour of sequencing yi

  19. Slide 19: SBX-Fast workflow can sequence a genome in under 7 hours

    SBX-Fast workflow can sequence a genome in under 7 hours Optimized protocol skips amplification and leverages short run capability Sample SBX-Duplex Xpandomer SBX Variant Prep Library Prep Synthesis Sequencing Calls 2 μg DNA Blood 20 min 120 min 140 min 20 min 60 min Enzymatic fragmentation / Reduce

  20. Slide 20: SBX-Simplex applications

    SBX-Simplex applications Combination of high-throughput and read length enable more efficient translational research Short read counting applications Longer reads for novel isoform detection Read count (M) Read length (100 bp bins) • 1M cell PerturbSeq experiment performed • 5’ Gene Expression (GEX)

  21. Slide 21: Roche analysis pipelines and open source tools development

    Roche analysis pipelines and open source tools development Solution will include on-premise acceleration to enable concurrent data processing Roche On-Premise Local Accelerated Partner / Primary / Post-Primary Analysis Pipeline Variant Calling Customer Cloud SBX-D BAM / VCF Base Intramolecular Reads

  22. Slide 22: Potential uses for SBX technology

    Potential uses for SBX technology Ability to advance research, translational and clinical applications over time Whole Genome Spatial Sequencing Overall advance in sequencing • Ultra-high throughput, especially for single Whole Exome cell, spatial, proteomics applications Sequencing Proteomics • Imp

  23. Slide 23: Roche uniquely positioned to use SBX to improve human health

    Roche uniquely positioned to use SBX to improve human health Roche has access to a unique ecosystem to drive sequencer content development Roche & Genentech Roche Diagnostics Drug development product development Open platform Roche tools Third-party tools (automation, library (library prep, prep, so

  24. Slide 24: Key takeaways

    Key takeaways NGS will grow at 9% Roche SBX has the Roche SBX Roche is building an per year driven by potential to deliver technology has the open platform which clinical and high accuracy with potential to will be the core of our biopharma segments unprecedented accelerate research end-to-end solut

  25. Slide 25: Invitations to upcoming events

    Invitations to upcoming events AGBT Roche Diagnostics Day 25 Feb 2025 27 May 2025 Sponsored workshop* London / hybrid event 18:05 – 19:05 CEST / 17:05 – 18:05 BST 14:00 – 16:30 CEST / 13:00 – 15:30 BST 12:05 – 01:05pm EDT / 09:05 – 10:05am PDT 08:00 – 10:30am EDT / 05:00 – 07:30am PDT Highlights: Hi

  26. Slide 26: Doing now what patients need next

    Doing now what patients need next

  27. Slide 27: Glossary

    Glossary • Q39 – Phred quality score (q-score), a logarithmic measurement of error likelihood • F1 score – measure of variant calling accuracy, which is the harmonic mean of precision and recall • GATK – Genome Analysis Toolkit, a commonly used software package for variant calling • Demux – short fo

Roche Holding — Technical Presentation (February 2025) on 6ix